EMERGENT BIOSOLUTIONS INC. Gain (Loss) on Disposition of Property (Deprecated 2013-01-31)
EMERGENT BIOSOLUTIONS INC. (EBS) reported Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) of $19.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfProperty · last filed 2012-05-04
- EMERGENT BIOSOLUTIONS INC. gain (loss) on disposition of property (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $19.00K.
- EMERGENT BIOSOLUTIONS INC. gain (loss) on disposition of property (deprecated 2013-01-31) for the quarter ending 2011-03-31 was -$13.00K.
- EMERGENT BIOSOLUTIONS INC. gain (loss) on disposition of property (deprecated 2013-01-31) for fiscal 2011 was -$392.00K, a 1131.58% decline from fiscal 2010.
- EMERGENT BIOSOLUTIONS INC. gain (loss) on disposition of property (deprecated 2013-01-31) for fiscal 2010 was $38.00K.
- EMERGENT BIOSOLUTIONS INC. gain (loss) on disposition of property (deprecated 2013-01-31) for fiscal 2009 was -$61.00K.
| Period end | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 3 month | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 12 month |
|---|---|---|
| 2012-03-31 | $19.00K 10-Q · filed 2012-05-04 | |
| 2011-12-31 | -$392.00K 10-K · filed 2012-03-09 | |
| 2011-03-31 | -$13.00K 10-Q · filed 2012-05-04 | |
| 2010-12-31 | $38.00K 10-K · filed 2012-03-09 | |
| 2009-12-31 | -$61.00K 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |